Cardiac Rhythm Management
banner Zoll 2016 Webcast wcdt

 

Activity Description

This activity has been designed to fulfil educational needs that underlie existing practice gaps by assessing the impact of wearable cardioverter defibrillator therapy to optimize patient care, through an evaluation of outcomes data, practice guidelines, and management considerations.

Cardiac Rhythm Management

Access Presentation

Webcast

Click on the session title listed below to view each presentation.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

Zoll LA16 Ulrica Green Pres

Introduction and Review of Wearable Cardioverter Defibrillator

Ulrika Birgersdotter-Green, MD

play-webcast

Zoll LA16 Craig Delaughter Pres

Clinical Implementation of the Wearable Cardioverter Defibrillator after WEARIT-II

Craig Delaughter, MD, PhD, FACC

play-webcast

Zoll LA16 Jeanne Poole Pres

Case Studies - Indications for the Wearable Cardioverter Defibrillator

Jeanne Poole, MD

play-webcast

Zoll LA16 Panel

Panel Discussion

Panel: Ulrika Birgersdotter-Green, MD, Craig Delaughter, MD, PhD and Jeanne Poole, MD

play-webcast

Cardiac Rhythm Management

Commercial Supporter

This activity is supported by an educational grant from ZOLL

Sponsor

MediaSphere Medical, LLC and Cine-Med

 

Faculty

Faculty

Zoll LA16 Craig Delaughter Port

Craig Delaughter, MD, PhD, FACC
Director, Cardiac Electrophysiology
Baylor Heart and Vascular Hospital
Fort Worth, TX

Zoll LA16 Ulrika Green port

Ulrika Birgersdotter-Green, MD
Director, Pacemaker and ICD Services
Professor of Medicine
UC San Diego Health
San Diego, CA

Zoll LA16 Jeanne Poole Port

Jeanne Poole, MD  
Professor of Medicine
Director, Arrhythmia Service and Electrophysiology Laboratory
Attending Physician, University of Washington Medical Center
Seattle, WA

 

CME Information

CME Released: 10/20/2016; Valid for credit through 10/20/2017

Target Audience

This activity is intended to meet the educational needs of electrophysiologists, cardiologists, heart failure physicians, and other physicians and associated professionals with the clinical focus of managing patients with complex cardiac arrhythmias and at risk of sudden cardiac death.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Assess current challenges and limitations for managing patients with complex cardiac arrhythmias and those at risk of sudden cardiac death.
  • Review clinical evidence, guidelines and recommendations that support wearable cardioverter defibrillator therapy use within daily practice.
  • Evaluate the feasibility, safety, and efficacy of the wearable cardioverter defibrillator for optimizing outcomes within indicated patient populations.

Accreditation Statement

This enduring activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint-providership of Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the ACCME to provide continuing medical education for Physicians and is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s).
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1 Contact Hour for Nurses.

Disclosure

MediaSphere Medical and Cine-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Cine-Med and MediaSphere Medical employees and planners in control of content have indicated that they have no relevant financial relationships to disclose.

Faculty Disclosure Summary

Dr. Craig Delaughter discloses that he is on the speakers’ bureau for Medtronic, St Jude Medical, Biosense Webster, Inc., Bristol Myers Squibb, Pfizer, and ZOLL. He has also disclosed research study participation for St. Jude Medical, Biosense Webster, Inc., Medtronic, and Boston Scientific.

Dr. Ulrika Birgersdotter-Green discloses serving on the speakers’ bureau for Medtronic, St. Jude Medical, and Biotronik.

Dr. Jeanne Poole discloses serving as a consultant for Biotronik, Boston Scientific, Medtronic, PhysioControl, and St. Jude Medical, and holds equity in Cameron Health. Dr. Poole also discloses receiving fellowship education support from Biotronik, Boston Scientific, Medtronic, St. Jude Medical, as well as research support from AtriCure, Inc., Boston Scientific, and PhysioControl.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2016 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical.

CME/CE Test

CME/CE Test
  1. Management Considerations of the Wearable Cardioverter Defibrillator: Outcomes Data and Clinical Guidelines to Direct Optimal Patient Care
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Degree: *  
    Invalid Input
  8. Institution: *  
    Invalid Input
  9. Mailing Address:*  
    Invalid Input
  10. City: *  
    Invalid Input
  11. State: *  
    Invalid Input

  12. 1. In the U.S. alone, approximately 359,400 people of all ages experience EMS-assessed out-of-hospital non-traumatic SCA each year (about 1,000/day) and nine out of 10 victims die.
  13. Select one*  


    Invalid Input Please Select one

  14. 2. According to the Center for Medicare Services (CMS) National coverage determination for ICDS, which of the following clinical scenarios limit primary prevention ICD therapy?
  15. Select one*  






    Invalid Input Please Select one

  16. 3. In WEARIT-II, a prospective registry of patients using a Wearable Cardioverter Defibrillator (WCD), what percentage of WCD patients were able to successfully avoid ICD implantation due to recovery of their LVEF?
  17. Select one*  




    Invalid Input Please Select one

  18. 4. WCD therapy has advantages to bridge a decision for appropriate ICD therapy, including; protection from sudden death, avoidance of unnecessary implant and surgical risk, and keeps patients engaged in the system.
  19. Select one*  


    Invalid Input Please Select one

  20. 5. The AHA Science Advisory Statement concludes that Sudden Cardiac Death (SCD) remains an important and preventable cause of death, and despite their obvious benefits, current defibrillator technologies have limitations and risks, including transient contraindications to implanted device therapy which commonly arise in clinical practice. Which of the following advisory statement on WCDs is accurate?
  21. Select one*  






    Invalid Input Please Select one

  22. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  23. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  24. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  25. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  26. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  27. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  28. Assess current challenges and limitations for managing patients with complex cardiac arrhythmias and those at risk of sudden cardiac death.
    Invalid Input Please Select one

  29. Review clinical evidence, guidelines and recommendations that support wearable cardioverter defibrillator therapy use within daily practice.
    Invalid Input Please Select one

  30. Evaluate the feasibility, safety, and efficacy of the wearable cardioverter defibrillator for optimizing outcomes within indicated patient populations.
    Invalid Input Please Select one

  31. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  32. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  33. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  34. Enhanced my current knowledge base:
    Invalid Input Please Select one

  35. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  36. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  37. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  38. Addressed a professional practice gap:
    Invalid Input Please Select one

  39. Was free of commercial bias/influence:
    Invalid Input Please Select one

  40. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  41. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  42. (*) Required Fields
  43. Invalid Input

Cardiac Rhythm Management